GB1297719A - - Google Patents

Info

Publication number
GB1297719A
GB1297719A GB1297719DA GB1297719A GB 1297719 A GB1297719 A GB 1297719A GB 1297719D A GB1297719D A GB 1297719DA GB 1297719 A GB1297719 A GB 1297719A
Authority
GB
United Kingdom
Prior art keywords
composition
copolymer
methacrylate
botfly
waterdispersible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US4558070A priority Critical
Application filed filed Critical
Priority to NL7113971A priority patent/NL7113971A/en
Publication of GB1297719A publication Critical patent/GB1297719A/en
Application status is Expired legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Abstract

1297719 Veterinary composition RICHARDSON-MERRELL INC 11 Oct 1971 47245/71 Heading ASB A composition for preventing or treating infestation of the gastrointestinal tract of equine animals by botfly larvae comprises choline xanthate and a carrier. Other ingredients specified which may be present include: pregelatinized starch, polyoxyethylene sorbitan monolaurate, white oil, granular microcrystalline cellulose, magnesium aluminium silicate, sodium lauryl sulphate, polyvinyl pyrrolidone, corn starch, talc, magnesium stearate, flavouring, flavour or aroma enhancer, molasses, potassium sodium copper chlorophyllin complex. The composition may be in the form of a waterdispersible powder or of granules, spheroidal particles or tablets coated with either a copolymer of butyl methacrylate and dimethylaminoethyl methacrylate, a copolymer of methacrylic acid and methyl methacrylate or a mixture of polyethylene glycol and alfalfa meal. It may be administered by stomach tube.
GB1297719D 1970-06-11 1971-10-11 Expired GB1297719A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US4558070A true 1970-06-11 1970-06-11
NL7113971A NL7113971A (en) 1971-10-12 1971-10-12 Anti botfly larvae compsn - contg choline xanthate

Publications (1)

Publication Number Publication Date
GB1297719A true GB1297719A (en) 1972-11-29

Family

ID=26644688

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1297719D Expired GB1297719A (en) 1970-06-11 1971-10-11

Country Status (4)

Country Link
BE (1) BE774408A (en)
DE (1) DE2150539A1 (en)
FR (1) FR2158076B1 (en)
GB (1) GB1297719A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040590A2 (en) * 1980-05-21 1981-11-25 Aktiebolaget Hässle A pharmaceutical preparation having improved release properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2972613A (en) * 1959-03-09 1961-02-21 Dawe S Lab Inc Cyclic choline xanthate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040590A2 (en) * 1980-05-21 1981-11-25 Aktiebolaget Hässle A pharmaceutical preparation having improved release properties
EP0040590A3 (en) * 1980-05-21 1983-01-12 Aktiebolaget Hässle A pharmaceutical preparation having improved release properties

Also Published As

Publication number Publication date
BE774408A1 (en)
FR2158076B1 (en) 1975-02-07
FR2158076A1 (en) 1973-06-15
DE2150539A1 (en) 1973-04-19
BE774408A (en) 1972-02-14

Similar Documents

Publication Publication Date Title
US6358528B1 (en) Pharmaceutical formulation
KR930010586B1 (en) Process for preparing oral pharmaceutical preparation containing 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)-ethylidene)-oxy-(9s)-erythromycin
US5424075A (en) Delivery system for enhanced onset and increased potency
US5260068A (en) Multiparticulate pulsatile drug delivery system
US4309405A (en) Sustained release pharmaceutical compositions
CA1331341C (en) Covered retard forms
US6024981A (en) Rapidly dissolving robust dosage form
EP0670718B1 (en) Pulsatile particles drug delivery system
US4427648A (en) Dipyridamole-containing pharmaceutical form
CA1156554A (en) Alkaline analgesic capsule
AU736243B2 (en) Film coated tablet compositions having enhanced disintegration characteristics
RU2308263C2 (en) Controlled releasing of active ingredient into medium with high fat content
JP3937464B2 (en) Inflatable pharmaceutical form
BE1000434A5 (en) Dietary supplement multiple vitamins and minerals several bioavailable iron containing controlled release.
CA1275933C (en) Therapeutic composition containing ibuprofen
FI110354B (en) Process for the preparation of pharmaceutical granules
JP4053589B2 (en) Pharmaceutical and / or nutritional microcapsules for oral administration
AU719170B2 (en) Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids
KR100780156B1 (en) Taste masking coating composition
CN1112919C (en) Controlled release-initiation and controlled release-rate pharamceutical composition
FI48318C (en) The method of therapeutically active agent and / or barium sulphate p isältävän the capsule or the coated compressed tablet is prepared amiseksi oral drug administration.
DE1593907B1 (en) alpha [4- (p-subst.Phenyl) phenoxy] -carboxylic acids, their derivatives and pharmaceutical compositions containing these compounds
GB1033684A (en) Process for the production of tablets by the pressing of powder mixtures without previous granulation
US2887438A (en) Prolonged action tablets
DE4100920C2 (en)

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees